The European Medicines Agency (EMA) has launched a public consultation to collect input for a reflection paper on patient access to electronic product information (ePI).

The ePI is the future electronic product information for medicines, and it is the outcome of a joint EMA-Heads of Medicines Agencies (HMA)-EC collaboration to facilitate informed decision-making by patients and healthcare professionals and improve overall patient safety. The ePI is currently under development by the European Medicines Regulatory Network (EMRN) and in the coming years, once created, will become a part of routine regulatory procedures. That’s why in this stage is particularly important the involvement of patients, healthcare professionals and representative organisations to ensure that the needs of the end-user are met. The reflection paper explores how the consumers can access up-to-date information on medicines safety, benefits and conditions of use, in their preferred language where available by using a smartphone to scan a 2D barcode on the medicine packaging. In this context, regulators are encouraging and supportive of any future industry-led initiative to create a solution for medicines with EU-wide coverage, as this could help ensure equal access to ePI for all EU citizens.

You can send your feedback to this public consultation by 30 June 2025 via the form available below: https://ec.europa.eu/eusurvey/runner/ePIReflectionPaper